Ranbaxy receives final US FDA approval

Ranbaxy Laboratories Limited (RLL) announced today that the Company has received final approval from the U.S. Food and Drug Administration to manufacture and market Cetirizine Hydrochloride Oral Solution (Allergy) and Children